US Patent 9617345 Anti-CEACAM5 antibodies and uses thereof
Patent 9617345 was granted and assigned to Sanofi on April, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 19, 2015
Date of Patent
April 11, 2017
Patent Applicant
Patent Application Number
14716377
Patent Citations Received
Patent Inventor Names
Béatrice Cameron
0
Alexey Rak
0
Francis Blanche
0
Hervé Bouchard
0
Paul Ferrari
0
Pierre-Francois Berne
0
Stéphanie Decary
0
Tarik Dabdoubi
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9617345 Anti-CEACAM5 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
